US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Stef (0NY3) 銘柄情報

Stef (0NY3)

110.20

0.00

(0.00%)

終了 7月7日 12:30AM

Stef (0NY3) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

110.20

( - )

買値

110.20

売値

110.20

出来高

370

0.00 日の範囲 0.00

110.20 52 週間の範囲 110.20

時価総額

前日終値

110.20

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

3,602 €

発行済株式数

12,649,263

配当利回り

2.7 (2.28%)

PER

18.14

1 株当たり利益 (EPS)

6.66

歳入

5.12B

純利益

84.25M

STEF SA provides temperature-controlled road transport and logistics services for agri-food industry. It transports fresh, frozen, and temperature sensitive products; and seafood products. The company also provides co-packing and manufacturing services; and out-of-home food services. It operates in ... STEF SA provides temperature-controlled road transport and logistics services for agri-food industry. It transports fresh, frozen, and temperature sensitive products; and seafood products. The company also provides co-packing and manufacturing services; and out-of-home food services. It operates in France, Italy, Spain, Portugal, Belgium, the Netherlands, Switzerland, and the United Kingdom. The company was founded in 1920 and is headquartered in Paris, France. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.stef.com

本社

Paris, France

設立

2026

Stef is listed in the sector of the ロンドン証券取引所 with ticker 0NY3. The last closing price for Stef was 110.20 €. Over the last year, Stef shares have traded in a share price range of 110.20 € to 110.20 €.

Stef currently has 12,649,263 shares in issue. The market capitalisation of Stef is 1.39 € billion. Stef has a price to earnings ratio (PE ratio) of 18.14.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	110.2	110.2	110.2	73	110.2	DE
52	0	0	110.2	110.2	110.2	32	110.2	DE
156	0	0	110.2	110.2	110.2	45	110.2	DE
260	0	0	110.2	110.2	110.2	152	110.2	DE

0NY3 - Frequently Asked Questions (FAQ)

What is the current Stef share price?

The current share price of Stef is 110.20 €

How many Stef shares are in issue?

Stef has 12,649,263 shares in issue

What is the market cap of Stef?

The market capitalisation of Stef is EUR 1.39B

What is the 1 year trading range for Stef share price?

Stef has traded in the range of 110.20 € to 110.20 € during the past year

What is the PE ratio of Stef?

The price to earnings ratio of Stef is 18.14

What is the cash to sales ratio of Stef?

The cash to sales ratio of Stef is 0.3

What is the registered address of Stef?

The registered address for Stef is 93, Boulevard Malesherbes, Paris, Ile-de-France, 75008

What is the Stef website address?

The website address for Stef is www.stef.com

doccjc

The Bashers narrative will always change.Ignore their bs . We are headed towards human trials at the Mayo Clinic .The science works .

Mrs kronwell

Mrs kronwell 5分前

PS, when I mentioned an and p at 23x, I was referencing the ootentisl upside, if management can convince street 2028- and beyond is looking good. The CFO hiring told me more than anything on that front. Doubt he’d take job if there wasn’t a pretty bright outlook!!!

Trooperstocks

Trooperstocks 6分前

$ZENA ZenaTech’s Drone as a Service (@daasplatform) attended the PGA John Deere Classic, held July 1–5, 2026, at TPC Deere Run in Silvis, Illinois.

Throughout tournament week, the DaaS team connected with golf industry professionals, local businesses, and the public as we showcased ou

Trooperstocks

Trooperstocks 6分前

$ZENA ZenaTech’s Drone as a Service (@daasplatform) attended the PGA John Deere Classic, held July 1–5, 2026, at TPC Deere Run in Silvis, Illinois.

Throughout tournament week, the DaaS team connected with golf industry professionals, local businesses, and the public as we showcased ou

DrHigh

correct. if it takes management 20 more years so be it. doesn't matter the condition of the submission. doesn't matter that they refuse to inform markets, media about this safe and effective life saving treatment. LP can do what she wants whenever she wants and we are never to question her. we work

Mr. Dragon

Mr. Dragon 7分前

The conman is back.

MightyX

MightyX 8分前

The-more yall deny obvious-facts..the-more apparent yalls lack-of desire-for-truth becomes.

gitreal

gitreal 8分前

To da MOON!!? Should investors LOAD DA BOAT?

Maybe an audit is coming? What do you think?

Mrs kronwell

Mrs kronwell 8分前

Not sure if you me a bear, if so, you’ve got one wrong. I’ve been in since 2006, added in 2010. Those are my only trades. I’ve been frustrated for sure, since I work in tech and should have reallocated some to Nvidia and honestly Apple in 2007, when sat though the greatest Preso I’ve ever seen by

joe botts

joe botts 9分前

Last time the OTC was Hot was then. Please , so many sub pennies ran.

ProfitChaser

ProfitChaser 9分前

According to the tweet a few days ago they are still moving forward. Another tweet today but the one from last week looks promissing. One of these days hopefully the company will start buying some shares or put out some info that will get the price moving up. IMO it wont take much.
From the

dexprs

That is a great idea Eric. We shall be only a few hundred miles apart and we can even meet this time around. :)

jondoeuk

jondoeuk 9分前

You are conflating multiple separate issues.

First, NWBO chose PFS as the primary endpoint. If pseudoprogression made PFS an unsuitable endpoint, that reflects a limitation of the trial design, not a reason to ignore the fact that the prespecified randomised primary endpoint was negat

callmepadrino

callmepadrino 10分前

This is the first FDA approval I’ve ever seen on the OTC as far as I can recall

SC8

Surprised they got this limited trial with the lack of good animal demos, but what a market dud on the unexpected good news. Guess people in the know realize the tech is public domain now and a competitor is over 4 years ahead to human trials. In short, Radiogel will never be a blockbuster as anyo

ignatiusrielly35

ignatiusrielly35 10分前

Yep. Up 200% in a few short months.

H~E Pennypacker

H~E Pennypacker 10分前

Just curious - what was the SS of $@#$*?

Golden Cross

Golden Cross 10分前

Large bids usually a sign we are going higher soon...

MysticProdigy77

MysticProdigy77 11分前

Can we close 0008?

SPORTYNORTY

SPORTYNORTY 11分前

Agree 100%. Well stated and wholly accurate.

TenKay

TenKay 11分前

Another billion shares added to the OS…

TexasMarvL

TexasMarvL 11分前

I like BTG a lot. Last time I updated my spreadsheet BTG was 12% of my gold and silver equity holdings. Their cash flow should provide a healthy opportunity here for shareholders.
Good luck to you!

Top Penny

Top Penny 12分前

Not by a long stretch??? On what planet??? Trips to over a dollar??? I disagree, however I can see a quarter a share with $PSRU without a reverse in due time!

moczowy

moczowy 12分前

https://www.linkedin.com/posts/paul-m-michaels_reformulating-diabetes-drug-to-treat-degenerative-activity-7479951170598375424-Peve?utm_source=share&utm_medium=member_android&rcm=ACoAAC5SabIBtz_AOYFB3farfCgsByhy2x4zCeg

Fifth Third Bancorp

Eyecity Com (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。